Independence Policy

Our Commitment

483 Signal maintains complete editorial and financial independence from:

• Consulting firms
• Compliance software vendors
• Training providers
• Contract manufacturing organizations
• Pharmaceutical manufacturers
• Any entity with a commercial interest in FDA inspection outcomes

Revenue Model

483 Signal generates revenue exclusively through subscriptions:

• Free newsletter (advertising-supported, no ads currently)
• Paid Pro membership

We do not accept:

• Sponsored content
• Vendor partnerships
• Referral fees
• Consulting engagements
• Speaking fees from commercial entities

Why This Matters

Most inspection intelligence comes from firms that sell remediation services. Their analysis is designed to generate consulting leads, not operational insight.

483 Signal's business model depends on providing analysis worth reading. We have no incentive to create anxiety that requires expensive solutions. We explain what findings mean and what to check internally. We don't offer to fix it for you.

Questions

For questions about this policy: contact@483signal.com